28 Monitored Medical Consumables Under Intensified Price Governance: National Policy Tightens Oversight on High-Value Devices

Reproduction without authorization is prohibited, and reproduction is allowed 24 hours later!

On December 31, 2025, the Ningxia Medical Insurance Bureau released the "Notice on LaunchingManagement of Price Risk for Medical Consumables Listed OnlineNotice on Work" (hereinafter referred to as the "Notice").

In order to further strengthen price management, the Notice clearly states that the region will...Purchase AmountPreviouslySuspected High-Price RiskThe types of consumables included in the key monitoring require enterprises to comply within the specified time.Adjust to the lowest price in China for online listing, or the listing will be directly suspended if overdue or in violation.

According to reports,The medical consumables price governance products announced this time total 28 types., involvingJohnson & Johnson, Boston Scientific, Fujifilm, Weigao, TuoRen, BD, Fresenius, Erbe, Olympusetc.30 Well-Known Medical Device Companies.

The Notice requires that relevant enterprisesNeed to be completed before January 28, 2026., confirming the lowest provincial level currently in ChinaValid online listing price and upload price commitment letter and online listing screenshot as evidence, after the review is approved, it will be linked and adjusted to the platform's listed price, which must not exceed the lowest valid price in other provinces.

It is worth mentioning that, compared with the 30-day price adjustment validity period in other provinces, this Notice also proposes that if a new provincial minimum listed price emerges after the conclusion of this governance, enterprises must...Active price adjustment within 20 working days。

In addition,TargetingConsumables already listed online but not included in this governance, and must complete the self-inspection and reduce prices within 20 days., enterprises that fail to respond within the prescribed time, refuse to adjust prices without special reasons, or engage in fraud will have their product listing qualifications directly suspended to eliminate "loophole exploitation" behavior.

As the year-end approaches, Ningxia's move is not an isolated case,Shanghai, Chongqing, Hebei and other places have recently密集出台verification, price adjustment, and penalty policies., a coverageAll Categories, Cross-RegionalThe price governance storm has comprehensively swept through the industry!

The implementation of Ningxia's policy is a microcosm of the deepening governance of medical consumable prices across China. In the past year, multiple provinces and cities in China have密集ly introduced硬核 measures, forming a unified governance situation across China.

December 22, 2025ShanghaiThe Sunshine Pharmaceutical Procurement Network issued a notice, stating that an investigation found multiple companies had underreported, misreported, or failed to report when maintaining prices from other provinces and cities. It was decided that, starting from 0:00 on December 24, 2025,Suspend the procurement qualification of 597 consumables, lasting for one year. The categories involved include commonly used consumables such as electrosurgical loops, disposable hemostatic clips, and circular external fixation frames.

ChongqingThe drug exchange also recently issued a notice to initiate the verification and adjustment of online listing prices for medical consumables, covering a wide range.Non-centralized procurement selected consumables normally listed online as of December 19, 2025Among them, non-selected products related to centralized procurement such as coronary stents and artificial joints need to be adjusted according to the price ceiling set by the state and Tianjin.

Enterprises need toBefore January 14, 2026Apply for adjustment proactively according to the lowest price in China; after January 22, 2026, irregular price comparisons will also be carried out, and products that conceal information or fail to update prices on time will have their prices reduced by 10% based on the lowest price in other provinces.If the company fails to confirm within the specified time, its online listing qualification will be revoked and will not be accepted for two years.

HebeiIt also clearly addresses the rectification work for issues such as "non-standard codes, failure to match codes, duplicate submissions, and prices higher than 1.8 times the average price of the same group" regarding the listed consumables and testing reagents. Enterprises are required to...Before January 20Complete the maintenance of relevant information. Those who fail to complete it within the deadline will have their online procurement qualification suspended to ensure standardized online data and reasonable prices.

AndLiaoning ProvinceAlso onStarting from the 7th of this month, officially implementing a new round of medical consumables price adjustment results, including 1,086 types of consumables such as bio-patches for cardiac surgery and metal bone needles have been adjusted. By December 2025, Liaoning49 batches of consumable price adjustments have been implemented, with the price reduction effect continuing to be released.。

In addition,Hunan, Hubei and other regionsHunan synchronizes governance by linking price reporting with procurement credit evaluations; products with falsely reported prices need to reduce their online listing price by 5%. Hubei has opened a green channel for innovative products and those needed for public health emergencies, allowing priority online listing if they commit to not exceeding the lowest price in other provinces, achieving a balance of "strict governance + differentiated treatment."

Nowadays, the governance of medical consumables prices in China has entered "Normalization, Refinement, Full Coverage"Phase."The core rule is "price linkage goes low, not high."The consequences of concealing or underreporting, as well as failing to adjust prices within the deadline, are continuously increasing.

At the same time, various regions activelyReserve Ample Development Space for Innovative Products. The entire medical consumables industry is like a giant ship, moving away from the old channel of "price competition,"Steadily Sailing Towards a New Journey of "Compliance + Value Competition"。